Although ABCC10 was shown to be highly expressed in non-small cell lung cancer cells and serves as a predictive marker for multi-drug resistance, our results show that it can be further elevated by cancer cell exposure to an alkylating drug—cisplatin [34,36]. The gene discussed is ABCC10; the disease is non-small cell lung carcinoma.